Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy (Q57902945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author

Katherine L Nathanson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

J V Cohen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

L Chiel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

L Boghossian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

M Jones

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

J E Stopfer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

J Powers

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

T R Rebbeck

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

S M Domchek

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

69-75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Meta-analysis of BRCA1 and BRCA2 penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Prophylactic Oophorectomy Reduces Breast Cancer Penetrance During Prospective, Long-Term Follow-Up ofBRCA1Mutation Carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Gynecologic Surgeries and Risk of Ovarian Cancer in Women With BRCA1 and BRCA2 Ashkenazi Founder Mutations: An Israeli Population-Based Case-Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Fracture risk after bilateral oophorectomy in elderly women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Ovarian conservation at the time of hysterectomy for benign disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Effect of bilateral oophorectomy on women's long-term health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-011-9480-8

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

21 January 2018

1 reference

12 December 2020

The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy

1 reference

12 December 2020

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

1 reference

12 December 2020

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group

1 reference

12 December 2020

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers

1 reference

12 December 2020

Fracture risk following bilateral oophorectomy

1 reference

12 December 2020

10.1007/S10689-011-9480-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21898151%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference